Testing effectiveness (Phase 2)Study completedNCT01718847
What this trial is testing
NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors
Who this might be right for
Increased Drug Resistance
National OncoVenture 40